Sign in

CIK 0000072444

  • Accelerated filer
  • Smaller reporting company

Vaxart, Inc.

Sign in to watch
Ticker
VXRT
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
591212264
Phone
+1 650-550-3500
Business address
310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
Former names
Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
  1. 4 Grant or award Director acquired 7,375 shares (grant or award)
  2. 4 Grant or award Chief Financial Officer acquired 22,500 shares (grant or award)
  3. 4/A Grant or award Chief Financial Officer acquired 101,652 shares (grant or award)
  4. 4 Grant or award President, Chief Exec Officer acquired 367,735 shares (grant or award)
  5. 4 Grant or award SVP, General Counsel acquired 187,606 shares (grant or award)
  6. 4 Grant or award Chief Financial Officer acquired 191,652 shares (grant or award)
  7. 4 Grant or award SVP, Chief Scientific Officer acquired 189,157 shares (grant or award)
  8. 4 Grant or award Chief Medical Officer acquired 194,350 shares (grant or award)
  9. 4 Grant or award Chief Financial Officer acquired 68,750 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Open-market buy Director bought 20,000 shares at $0.76 ($15,140)
  12. 4 Open-market sale Director sold 1,500 shares at $6.01 ($9,015)
  13. 4 Gift Director gave 26,240 shares (gift)
  14. 4 Grant or award Director acquired 14,750 shares (grant or award)
  15. 3 Insider Initial Statement of Ownership
  16. 4 Option exercise Director acquired 26,240 shares (option exercise)
  17. 4 Grant or award Director acquired 14,750 shares (grant or award)
  18. 4 Grant or award Director acquired 7,375 shares (grant or award)
  19. 4 Grant or award Director acquired 7,375 shares (grant or award)
  20. 4 Grant or award Director acquired 7,375 shares (grant or award)

Page 5 of 28 · 550 filings